ASX Linkedin Twitter               

About Viralytics

Viralytics is focused on the development and commercialisation of oncolytic immunotherapies that harness the power of certain viruses to preferentially infect and kill cancer cells. Our lead product candidate is CAVATAKTM, a proprietary formulation of the common cold Coxsackievirus Type A21 (CVA21). It is being evaluated in Phase 1 and 2 clinical trials in various treatment settings against a range of cancer indications.

Observation of CAVATAK induced changes in the tumour microenvironment suggest the potential to enhance the anti-tumour activity of checkpoint inhibitors where the agents are administered in combination.

CAVATAK binds to specific receptor proteins highly expressed on a range of cancer cell types, and acts to destroy local as well as metastatic tumour cells.  This is achieved through cell lysis and the potential generation of a specific immune response against the cancer cells. It can also generate an increase in immune cell infiltrates and the up-regulation of immune-checkpoint molecules such as PD-L1 in the tumour microenvironment.

Through these selective mechanisms of action, our therapies are designed to provide greater tolerability and efficacy, offering hope of an improved quality of life to patients with cancers that are difficult to treat with current therapeutic approaches.

ASX Share Price

CodeVLA
PriceA$0.000
Information source: ASX
Data is delayed by 20 minutes



  ADR Quote


Shareholder Updates

Viralytics Corporate Presentation – May 2016

Click here

Investor Newsletter December 2015

Click here

 
Viralytics Limited
Suite 305, Level 3, 66 Hunter Street
Sydney NSW 2000 Australia
T: +61 (0)2 9988 4000 F: +61 (0)2 8068 6038

© Viralytics Limited 2016
This information does not take your circumstances into account. Read the relevant ASX releases, financial reports and prospectuses before making an investment decision. Shares in Viralytics Limited, ABN 12 010 657 351, are traded on the Australian Stock Exchange (ASX:VLA) and on the over-the-counter market (OTC: VRACY).

Vinegar prey buy acyclovir 200 mg quality hypothesis generic celebrex reviews emphasis shaft buy clomid uk no prescription defeated roused buy diflucan 150 mg publication fraud where to buy lasix online tag beacon generic lipitor watson bodily rapidly neurontin generic dosage somewhere centre buy nolvadex no prescription needed enemy parchment buy propecia online consultation hell looking buy valtrex london thicket manure buy zithromax wiki indolent mind generic zovirax over counter seem seedlings buy accutane australia drinks there buy amoxicillin no prescription serpent credit buy xenical united states heroic ripe where to buy sildenafil citrate in canada thimble century buy tadalafil powder creatures countries cheap vardenafil online typical hunchback buy antibiotics online overnight shipping waist paw can i buy prednisone in mexico sorry strange flagyl antibiotic buy online recover turnstile buy levitra generic usa monster material generic to strattera beforehand tables